29 articles
Wales launched Wim's Protocol to prevent clozapine deaths, after drug interactions raised blood levels by up to 112 percent in schizophrenia patients.
HLP003, a psychedelic-derived add-on therapy, could help the 50% of depression patients whose antidepressants fall short before they become.
The VA is pushing ibogaine as a PTSD and addiction treatment for veterans, while Eli Lilly's $3.8B psychedelic acquisition signals a medical revolution.
Arizona authorized secure mental illness facilities in 2019, but seven years later none have opened, leaving nearly 2,000 people cycling through crisis.
Brain-targeted MRI scans may help the 30-40% of teens whose depression doesn't respond to standard treatment by personalizing where magnetic stimulation.
A New Mexico court ordered Meta to pay $567 million for teen mental health harms, with $420 million going directly to treatment services for affected.
School smartphone bans show no mental health benefit for teens, new research finds; experts say broader action on platform design is needed.
Preteen suicide in the U.S. hit a record 194 deaths in 2025, with rates rising 8.2% yearly as experts warn warning signs are being missed.
Over 80 percent of mental health directory listings are inaccurate, leaving patients unreachable providers and surprise bills despite landmark new access.
Genetic markers fail to predict quetiapine's cognitive benefits in schizophrenia, but lower doses show surprising improvements in working memory.
About 4 in 10 teens experience irritability weekly worldwide, and a major study links it most strongly to depression, making it a key mental health.
Psychiatrists often keep patients on failing medications due to therapeutic inertia, a pattern a 2026 framework says leaves serious mental illness.
AI chatbots mentioned suicide 1,275 times with one struggling teen; experts warn companion apps pose deadly mental health risks for adolescents.
Eli Lilly's $2.8 billion acquisition of AtaiBeckley signals that psychedelic-assisted therapy for treatment-resistant depression has entered the.
Seven in 10 Americans would call 988 in a crisis, but fears about police, costs, and forced hospitalization are keeping many from dialing.
FDA's new psychedelic trial guidance directly addresses functional unblinding, the bias that derailed MDMA therapy approval, setting strict design rules.
Psilocybin therapy may win FDA approval by 2027, but only 5% of eligible patients access similar treatments today, revealing a deep infrastructure crisis.
Nearly 6 in 10 long-term lithium users show accelerated kidney decline, a major study finds, raising urgent questions for bipolar disorder patients and.
MacKenzie Scott donated $20 million to Active Minds as CDC data shows one in five teens have seriously considered suicide.
Psilocybin's benefits last six months in a landmark Phase III trial, while cheaper intramuscular ketamine matches Spravato for treatment-resistant.
Clozapine may reduce psychiatric hospitalizations for bipolar disorder and depression, a study of 500,000 patients from Finland and Sweden finds.
A two-week PTSD treatment program compresses months of therapy into intensive sessions, helping veterans recover faster with no travel costs.
Yoga and meditation reduced anxiety in emergency room doctors by 6 weeks, with yoga showing greater benefits than meditation alone for stressed residents.
Federal prosecutions and shutdowns have drastically reduced telehealth mental health options, leaving ADHD and anxiety patients with fewer choices.
Employees using AI tools report 45% higher burnout rates, creating technostress that leads to anxiety and depression in millions of workers.
Mental health symptoms quietly sabotage work performance through subtle signs like brain fog and procrastination that most people dismiss as stress.
Ketamine therapy has moved from experimental treatment to mainstream mental health care, with 88.8% of patients showing improvement in depression.
Prenatal depression affects many pregnant women but often goes undiagnosed because symptoms mimic normal pregnancy changes, experts warn.
Cannabis withdrawal triggers anxiety as your brain readjusts without THC, but symptoms like sleep issues and cravings typically improve within weeks.
